Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway.
Department of Pediatrics, Haukeland University Hospital, Bergen, Norway.
Physiol Rep. 2021 Jun;9(11):e14857. doi: 10.14814/phy2.14857.
Patient-derived organoids have revolutionized biomedical research and therapies by "transferring the patient into the Petri dish". In vitro access to human lung organoids representing distal lung tissue, i.e. alveolar organoids, would facilitate research pertaining to a wide range of medical conditions and might open for a future approach to individualized treatment.We propose a protocol to derive a single human lung biopsy towards both alveolar and bronchiolar organoids. By modulating Wnt pathway, we obtained a differential gene expression of the main markers for both subtypes, such as a higher expression of surfactant protein C in alveolar organoids or a higher expression of mucine 5AC in bronchiolar organoids. Although the specific cell enrichment was not complete, the differentiation was observed as early as passage 1 based on morphology, and confirmed by QPCR and histology at passage 2. These results are consistent with a functional specification of lung epithelium towards both alveoli- and bronchi-enriched organoids from first passages.
患者来源的类器官通过“将患者转移到培养皿中”彻底改变了生物医学研究和治疗。体外获得代表远端肺组织的人类肺类器官,即肺泡类器官,将有助于广泛的医学条件的研究,并可能为未来的个体化治疗方法开辟道路。我们提出了一个从单个人类肺活检中获得肺泡和细支气管类器官的方案。通过调节 Wnt 通路,我们获得了两种亚型的主要标志物的差异基因表达,例如在肺泡类器官中表面活性剂蛋白 C 的表达更高,或在细支气管类器官中粘蛋白 5AC 的表达更高。尽管特定细胞的富集不完全,但根据形态学,在第 1 代即可观察到分化,在第 2 代通过 QPCR 和组织学进一步证实。这些结果与从第一代开始,肺上皮细胞向富含肺泡和细支气管的类器官的功能特化一致。